These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
Filed by the Registrant
☒
|
||||||||
Filed by a Party other than the Registrant
☐
|
||||||||
Check the appropriate box: | ||||||||
☐ | Preliminary Proxy Statement | |||||||
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||||||
☒ | Definitive Proxy Statement | |||||||
☐ | Definitive Additional Materials | |||||||
☐ | Soliciting Material under §240.14a-12 |
AptarGroup, Inc. | |||||||||||
(Name of Registrant as Specified In Its Charter) | |||||||||||
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) | |||||||||||
Payment of Filing Fee (Check the appropriate box): | |||||||||||
☒ | No fee required. | ||||||||||
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | ||||||||||
(1) | Title of each class of securities to which transaction applies: | ||||||||||
(2) | Aggregate number of securities to which transaction applies: | ||||||||||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | ||||||||||
(4) | Proposed maximum aggregate value of transaction: | ||||||||||
(5) | Total fee paid: | ||||||||||
☐ | Fee paid previously with preliminary materials. | ||||||||||
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | ||||||||||
(1) | Amount Previously Paid: | ||||||||||
(2) | Form, Schedule or Registration Statement No.: | ||||||||||
(3) | Filing Party: | ||||||||||
(4) | Date Filed: | ||||||||||
NOTICE OF 2021 ANNUAL MEETING OF STOCKHOLDERS | |||||||||||
When? | Where? | Who? |
![]() |
||||||||
![]() |
![]() |
![]() |
|||||||||
9:00 a.m. CDT
on Wednesday, May 5, 2021 |
Live webcast online at
www.virtualshareholdermeeting.com/ATR2021 |
Stockholders of Record
as of March 12, 2021 |
Proposal |
Board
recommendation |
For more
information |
||||||
1. To elect the four director nominees named in the proxy statement to terms of office expiring at the annual meeting in 2024 |
FOR
all of the nominees named in the proxy statement for election to the Board of Directors
|
Page 7 | ||||||
2. To approve, on an advisory basis, Aptar’s executive compensation
|
FOR
the resolution to approve executive compensation
|
Page 23 | ||||||
3. To ratify the appointment of the independent registered public accounting firm for 2021 |
FOR
the ratification of the appointment of the independent registered public accounting firm for 2021
|
Page 24 |
![]() |
![]() |
![]() |
|||||||||
Internet
(Preferred Voting Method)
|
Telephone | ||||||||||
www.proxyvote.com |
1-800-690-6903 up until 11:59 pm Eastern Time, on May 4, 2021
|
Mark, sign and date your proxy card and return it in the pre-addressed postage paid envelope we have provided or return it to: | |||||||||
up until
11:59 pm Eastern Time, on May 4, 2021 |
Vote Processing, c/o Broadridge
51 Mercedes Way Edgewood, NY 11717 |
![]() |
Sincerely, | ||||
/s/ Kimberly Y. Chainey | |||||
Kimberly Y. Chainey
Executive Vice President, General Counsel and Secretary
|
TABLE OF CONTENTS | |||||
Page | |||||
Compensation Discussion and Analysis
|
|||||
PROXY SUMMARY |
This summary highlights information contained elsewhere in this proxy statement. This summary does not contain all of the information that you should consider, and you should read the entire proxy statement carefully before voting. |
2021 Annual Meeting of Stockholders Information
|
||||||||||
Date and Time: | Wednesday, May 5, 2021 at 9:00 a.m. CDT | ||||||||||
Location: | Live webcast online at www.virtualshareholdermeeting.com/ATR2021 | ||||||||||
Record Date: | March 12, 2021 |
Help us “go green” and reduce costs. For those stockholders who are still receiving paper copies of our proxy statement and annual report, please consider requesting electronic delivery or a Notice which will reduce the amount of paper materials needed to conduct our annual meeting. You may do so by contacting your broker, visiting www.proxyvote.com or emailing us at investorrelations@aptar.com. |
![]() |
Name and Primary or Former Occupation | Age |
Director
Since |
Independent | Audit Committee |
Management
Development and Compensation Committee |
Corporate Governance Committee | ||||||||||||||||||||||||||||||||
Andreas C. Kramvis
Operating Partner at AEA Investors
|
68 | 2014 | ✔ |
![]() |
||||||||||||||||||||||||||||||||||
Maritza Gomez Montiel
Former Deloitte LLP executive
|
69 | 2015 | ✔ |
![]() |
||||||||||||||||||||||||||||||||||
Jesse Wu
Advisor to private equity firms
|
64 | 2018 | ✔ |
![]() |
||||||||||||||||||||||||||||||||||
Ralf K. Wunderlich
Consultant and senior advisor to private equity firms
|
54 | 2009 | ✔ |
![]() |
![]() |
Committee Chairperson |
![]() |
Member | ||||||||
![]() |
2021 Proxy Statement |
1
|
TOTAL SHAREHOLDER RETURNS (TSR)
TSR (DIVIDENDS REINVESTED)
|
AptarGroup |
S&P
500 Index |
S&P
400 Index |
Peer Group | |||||||||||
![]() |
![]() |
![]() |
![]() |
|||||||||||
Dec-15 | 100 | 100 | 100 | 100 | ||||||||||
Dec-16 | 102.76 | 111.96 | 120.74 | 112.13 | ||||||||||
Dec-17 | 122.62 | 136.40 | 140.35 | 138.44 | ||||||||||
Dec-18 | 135.55 | 130.42 | 124.80 | 126.46 | ||||||||||
Dec-19 | 168.72 | 171.49 | 157.49 | 155.41 | ||||||||||
Dec-20 | 202.25 | 203.04 | 179.00 | 190.88 |
$2.9 billion
Record Reported Sales
|
$214 million
Annual net income
|
$3.21
Annual diluted earnings per share
|
||||||
$570 million
Record Annual Cash Flow from Operations
|
(27%) and (30%)
Reduction in Total Recordable Incident Rate (TRIR), and Lost Time Frequency Rate (LTFR), respectfully, from the prior year
|
27th year
27th consecutive year of paying
an increased aggregate annual dividend amount
|
2
|
2021 Proxy Statement |
![]() |
✔ |
Independent
directors meet regularly in executive session.
|
✔ |
Annual
“Say-on-Pay Vote”
on executive compensation
|
||||||||
✔ | Prohibition on directors and executive officers from hedging or pledging stock | ✔ | Annual Board and Committee self-evaluations | ||||||||
✔ |
Majority voting
for directors and director resignation policy in uncontested elections
|
✔ |
Director
age limits
|
||||||||
✔ | Stock ownership requirements for directors and executive officers | ✔ | Separate independent Chairman & CEO |
INDEPENDENCE | TENURE | GENDER DIVERSITY | ||||||
![]() |
![]() |
![]() |
![]() |
2021 Proxy Statement |
3
|
OUR PHILOSOPHY | We believe the following factors are supportive of our compensation objectives: | |||||||
Our compensation philosophy is designed to fairly reward our executives for growing our business and increasing value for stockholders, and to retain our experienced management team. |
✔
Significant amount of
pay that is performance-based and/or at-risk
, with emphasis on performance-based pay to reward short- and long-term performance measured against pre-established objectives and a substantial amount provided in equity;
|
|||||||
✔
Stock ownership guidelines
, limits on executive officer stock trading and prohibition of hedging or pledging Aptar equity securities;
|
||||||||
✔
Employment and change‑in‑control agreements
that are designed to be competitive in markets in which we compete for executive talent;
|
||||||||
✔
Absence of tax gross‑up agreements
with named executive officers, other than those related to relocation benefits or expatriate assignments;
|
||||||||
✔
Use of an
independent compensation consultant
; and
|
||||||||
✔
Limited perquisites
other than common perquisites provided in the context of expatriate assignments or related to relocation.
|
4
|
2021 Proxy Statement |
![]() |
Our Belief System: | ||||||||
![]() |
![]() |
![]() |
||||||
We believe lives should be enriched from having worked for and with Aptar. | We believe that 100 percent of all plastic packaging should be recycled. | We believe the packaging industry must be circular, with repeatable and positive effects on people, the planet and products. |
Top 100 Most Responsible
Named one of "America's Most Responsible Companies 2021" by Newsweek and is ranked in the top 100 among 400 U.S. companies.
|
Top 100 Most Sustainable
Named one of the "Top 100 Most Sustainable U.S. Companies" by Barron's as part of their 2019 ranking.
|
United Nations Global Compact
Joined the United Nations (UN) Global Compact, the world's largest citizenship initiative, which focuses on universal principles in the areas of human rights, labor, environment and anti-corruption.
|
||||||
Gender and Diversity KPI Alliance
Joined the Gender and Diversity KPI Alliance, whose aim is the adoption and use of a set of Key Performance Indicators to measure gender and diversity in their companies and organizations.
|
ISS Prime Status
In December of 2020 we were upgraded to Prime status with ISS ESG, one of the leading rating agencies for sustainable investments.
|
CDP "A" List
Of the 5,800+ companies that disclose environmental metrics through the CDP, Aptar is among the 270 companies awarded an A score for Climate Change and also named a Superior Engagement Leader.
|
||||||
Partnering with CARE
Furthering women's education and economic empowerment. Early sponsor of the Fast + Fair COVID-19 Vaccine Response Campaign.
|
Gender Diversity Index ETF (SHE)
Aptar is included in the SPDR® SSGA Gender Diversity Index ETF (SHE) which invests in companies that rank among the highest in gender diversity within senior leadership.
|
Eco-efficient Operations
At year-end 2020, approximately 85% of our global electricity consumption is coming from renewable sources: 53% of Aptar sites were certified as "Landfill Free" through our internal program and globally we re-used or recycled more than 75% of all operational wastes.
|
![]() |
2021 Proxy Statement |
5
|
6
|
2021 Proxy Statement |
![]() |
PROPOSAL 1—ELECTION OF DIRECTORS |
THE BOARD OF DIRECTORS
RECOMMENDS A VOTE
FOR
EACH
OF THE FOLLOWING NOMINEES FOR DIRECTOR.
|
![]() |
2021 Proxy Statement |
7
|
ANDREAS C. KRAMVIS | |||||||||||
![]() |
Mr. Kramvis is an operating partner at AEA Investors (a private equity firm). Mr. Kramvis was Vice Chairman of Honeywell International (a multi‑industry company with presence in Aerospace, Automation and Controls, Chemicals and Automotive Industries) from April 2014 to February 2017. From 2008 to 2014, Mr. Kramvis was President and Chief Executive Officer of the Honeywell Performance Materials and Technologies group (a developer of processes and chemicals for oil refining, petrochemicals and a variety of high-purity, high-quality performance chemicals and materials). Mr. Kramvis is also a director of several privately-held companies. From 2014 to 2019, Mr. Kramvis was a director of Axalta Coating Systems Ltd. (a NYSE-listed developer, manufacturer and seller of liquid and powder coatings).
The Board of Directors concluded that Mr. Kramvis should continue to serve as a director of Aptar in part due to his experience from holding senior executive positions at Honeywell, as well as his management of several companies with global businesses across five different industries. This experience has also led the Board to determine that Mr. Kramvis is an “audit committee financial expert” as defined by the SEC.
|
||||||||||
Director since:
2014
Age 68
|
MARITZA GOMEZ MONTIEL | |||||||||||
![]() |
Ms. Montiel served as Deputy Chief Executive Officer and Vice Chairman of Deloitte LLP from 2011 through her retirement in May 2014. During Ms. Montiel’s tenure at Deloitte, she was the Advisory Partner for many engagements in which Deloitte was the principal auditor. Ms. Montiel has over 30 years of experience in leading and performing audits of various entities. Ms. Montiel is a director of McCormick & Company, Inc. (a NYSE-listed spice, herb and flavoring manufacturer); Royal Caribbean Cruises Ltd. (a NYSE-listed global cruise company) and Comcast Corporation (a Nasdaq-listed telecommunications company).
The Board of Directors concluded that Ms. Montiel should continue to serve as a director of Aptar due to her experience from holding senior management positions in a global accounting and consulting firm, and her years of experience in leading and performing audit engagements. This experience has also led the Board to determine that Ms. Montiel is an “audit committee financial expert” as defined by the SEC.
|
||||||||||
Director since:
2015
Age 69
|
JESSE WU | |||||||||||
![]() |
Mr. Wu is an advisor to private equity firms. From 2003 through 2016, Mr. Wu held senior leadership roles at Johnson & Johnson (multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company) including Chairman of Johnson & Johnson China and Worldwide Chairman of the company’s Consumer Healthcare Group. Mr. Wu was a director of The a2 Milk Company Limited (an ASX- and NZX-listed company that markets a2 milk and infant nutritional products globally) from May 2017 to February 2021, Shanghai Kehua Bio‑Engineering Co. Ltd. (a SZSE-listed manufacturer of in vitro diagnostic products) from May 2017 to June 2020, and Li‑Ning Company Limited (an HKSE-listed athletic shoes and sporting goods company) from August 2015 to March 2018.
The Board of Directors concluded that Mr. Wu should continue to serve as a director of Aptar due to his knowledge of and background in consumer products and his international experience, including his extensive experience working in China.
|
||||||||||
Director since:
2018
Age 64
|
RALF K. WUNDERLICH | |||||||||||
![]() |
Mr. Wunderlich is an independent consultant and a senior advisor to private equity firms. He is an advisor to the Board of Elif Packaging (a flexible packaging solution supplier), and a non-executive director for the Shepherd Building Group (privately owned, UK based portable buildings and construction business). He is currently a director of Essentra PLC (a LSE-listed supplier of plastic and fibre products) and Huhtamaki Oyj (a Nasdaq Helsinki-listed global food packaging company). He is a former member of Amcor Limited’s Global Executive Team and former President of the business group Amcor Flexibles Asia Pacific (packaging solutions). Mr. Wunderlich also formerly served as a Director of LINPAC Group and AMVIG Group.
The Board of Directors concluded that Mr. Wunderlich should continue to serve as a director of Aptar in part due to his senior executive positions at leading global packaging companies, his knowledge of and background in the packaging industry and his international experience in working with and from various European, American and Asian countries.
|
||||||||||
Director since:
2009
Age 54
|
8
|
2021 Proxy Statement |
![]() |
GIOVANNA KAMPOURI MONNAS | |||||||||||
![]() |
Ms. Kampouri Monnas is an advisor and serves on the boards of several global companies. Effective February 2021 she is a member of the Board of Directors and Chair of the Governance Committee for the Hellenic Corporation of Assets and Participations S.A. (HCAP), the enterprise which oversees all Greek state owned companies, services and assets. As of 2019, she was Chairman of Exea Ventures BV in the Netherlands, a global family investment company with diverse holdings in fragrances, fashion, skin care, real estate and venture funds, which was recently relocated to Spain.
Since 2006, Ms. Kampouri Monnas is also a director of Puig S.L. (a fashion, fragrance, cosmetics and skincare business). From 2006 to 2018, Ms. Kampouri Monnas was a member of the Supervisory board and Chairman of the Compensation Committee of Randstad Holding NV (the global world leader in the HR services industry, based in Amsterdam). From 2015 to 2018, Ms. Kampouri Monnas was a director of Imerys S.A. (a Euronext-listed producer of industrial minerals, based in France), while from 2005 to 2009 she was director of TNT BV. Her final executive role was President of Benckiser International, the German company that later was divided into Reckitt-Benckiser and Coty Inc.
The Board of Directors concluded that Ms. Kampouri Monnas should continue to serve as a director of Aptar in part due to her senior leadership positions in leading global consumer goods companies, The Procter & Gamble Company and Joh. Benckiser GmbH, her expertise in the fragrance and cosmetic markets, which are particularly important to Aptar, and her global marketing experience.
|
||||||||||
Director since:
2010
Age 65
|
ISABEL MAREY-SEMPER | |||||||||||
![]() |
Ms. Marey-Semper was a member of the Executive Committee of L’Oréal S.A. (personal care company and world’s largest cosmetic company), in charge of Communications and Public Affairs, from July 2015 to December 2017. Prior to this, Ms. Marey-Semper served from 2011 to 2015 as Vice President and Head, Advanced Research at L’Oréal. Prior to joining L’Oréal, Ms. Marey-Semper served in executive positions at established industrial companies such as Compagnie de Saint Gobain S.A. (a Euronext-listed French multinational manufacturer and distributor of building materials) and Stellantis, (formerly Group PSA Peugeot Citroën, a Euronext-listed French multinational manufacturer of automobiles and motorcycles). Ms. Marey-Semper is a director of the Imagine Institute (institute for medical research and treatment of genetic diseases), the Inria Foundation (research foundation dedicated to digital science and technology) and Damae Medical (a medical company focused on diagnosing skin tumors without the need for a biopsy). Ms. Marey-Semper was a director of Rexel (a Euronext listed French distributor of electrical supplies) from 2014 to 2016.
The Board of Directors concluded that Ms. Marey-Semper should continue to serve as a director of Aptar in part due to her experience from holding senior executive positions at L’Oréal, as well as other established companies, and her diverse and comprehensive experience in research, strategy, transformative programs, and finance.
|
||||||||||
Director since:
2019
Age 53
|
STEPHAN B. TANDA | |||||||||||
![]() |
Mr. Tanda became President and Chief Executive Officer of Aptar on February 1, 2017. Prior to this, Mr. Tanda served from 2007 until 2017 as an Executive Managing Board Director at Royal DSM NV (leading global supplier of ingredients and material solutions for the food, dietary supplement, personal care, medical device, automotive, paint, electronic and bio-material markets), where he was responsible for DSM’s Nutrition and Pharma activities, as well as DSM’s presence in the Americas and various corporate duties. Mr. Tanda is a director of Ingredion Incorporated (a NYSE-listed global supplier of high-quality food and industrial ingredient solutions). Mr. Tanda was a director of Patheon NV (formerly a NYSE-listed company that provided pharmaceutical development and manufacturing services) from March 2016 until the company was sold to Thermo Fisher Scientific in August 2017.
The Board of Directors concluded that Mr. Tanda should continue to serve as a director of Aptar due in part to his role as President and Chief Executive Officer, his extensive global experience leading and building successful business-to-business organizations in several markets currently served by Aptar, as well as his transaction and integration experience.
|
||||||||||
Director since:
2017
Age 55
|
GEORGE L. FOTIADES | |||||||||||
![]() |
Mr. Fotiades has been Chairman of the Board since 2018. Mr. Fotiades has been President and CEO of Cantel Medical Corp. (NYSE-listed manufacturer of infection prevention and control products) ("Cantel") since March 2019. He was Operating Partner at Five Arrows Capital Partners (Rothschild Merchant Banking) from April 2017 until March 2019. From 2007 through April 2017, he was Chairman and Operating Partner of Healthcare Investments at Diamond Castle Holdings LLC (private equity investing). He is a director of the following NYSE-listed companies: Prologis, Inc. (integrated distribution facilities and services) and Cantel Medical Corp. In January 2021, Cantel and STERIS plc signed a definitive agreement pursuant to which STERIS plc will acquire Cantel.
The Board of Directors concluded that Mr. Fotiades should continue to serve as a director of Aptar due to his extensive experience from previously held senior executive positions at leading healthcare and consumer product companies including Cardinal Health, Inc., Catalent Pharma Solutions, the former Warner-Lambert’s Consumer Health Products Group (now part of Johnson & Johnson) and Bristol-Myers Squibb’s Consumer Products, Japan division. The Board also considered his present and past board level experience with global organizations.
|
||||||||||
Director since:
2011
Age 67
|
![]() |
2021 Proxy Statement |
9
|
B. CRAIG OWENS | |||||||||||
![]() |
Mr. Owens was the Chief Financial Officer and Chief Administrative Officer of Campbell Soup Company (global producer and seller of canned soups and related products) from 2008 through 2014. Mr. Owens is a director of Crown Holdings, Inc. (a NYSE-listed designer, manufacturer and seller of packaging products and equipment for consumer goods and industrial products). He is a former director of Dean Foods Company (a U.S. food and beverage company) and a former director of J. C. Penney Company, Inc. (a U.S. department store chain).
The Board of Directors concluded that Mr. Owens should continue to serve as a director of Aptar due to his extensive experience in the consumer food and beverage industries, which is particularly relevant for Aptar’s Food + Beverage business, as well as his significant expertise in financial reporting, accounting, corporate finance and capital markets. This experience has also led the Board to determine that Mr. Owens is an “audit committee financial expert” as defined by the SEC.
|
||||||||||
Director since:
2018
Age 66
|
DR. JOANNE C. SMITH | |||||||||||
![]() |
Dr. Smith is a physician at the Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago) and became the Shirley Ryan AbilityLab’s President and Chief Executive Officer in 2006. Dr. Smith is a director of Performance Health, Inc. (rehabilitation and wellness products manufacturer). From 2003 to 2015, Dr. Smith was a director of Hill‑Rom, Inc. (a NYSE-listed healthcare and medical technology, formerly Hillenbrand Industries).
The Board of Directors concluded that Dr. Smith should continue to serve as a director of Aptar in part due to her executive background as President and Chief Executive Officer of a leading research and healthcare rehabilitation organization, her public company director experience, her knowledge of and background in the healthcare and medical technology industry, which is particularly relevant for Aptar’s Pharma business, and her strategic planning, operations and senior management experience.
|
||||||||||
Director since:
1999
Age 60
|
10
|
2021 Proxy Statement |
![]() |
Corporate Governance Documents | |||||
Corporate Governance Principles | |||||
Code of Conduct | |||||
Director Independence Standards | |||||
Board Committee Charters | |||||
![]() |
2021 Proxy Statement |
11
|
Code of Conduct | |||||
Conflicts of interest and fair dealing | |||||
Disclosure obligations | |||||
Confidentiality obligations | |||||
Prohibition of insider trading | |||||
Compliance with all laws, rules and regulations | |||||
Confidential, anonymous submission of concerns | |||||
12
|
2021 Proxy Statement |
![]() |
Board Member | Requirement | Current Required Value | |||||||||||||||
Non-Executive Director | Annual | ||||||||||||||||
5 | × | Cash | = | $500,000 | |||||||||||||
Retainer |
Audit |
Management
Development and Compensation |
Corporate Governance | ||||||
✔
Gender diverse and are chaired by women
|
||||||||
✔
Governed by a written charter approved by the Board
|
||||||||
✔
Comprised solely of independent directors
|
||||||||
✔
Decisions and actions reported to the full Board following each meeting
|
![]() |
2021 Proxy Statement |
13
|
M. Gomez Montiel,
Chair
A. Kramvis
B. Owens
|
✔ | Each member satisfies the heightened independence standards applicable to audit committee service | ||||||
✔ | Each member is an “audit committee financial expert” as defined by the SEC | |||||||
✔ | Oversees the financial reporting process, system of internal controls and audit process | |||||||
✔ | Reviews annual and interim financial statements | |||||||
✔ | Reviews the qualifications, independence and audit scope of the independent registered public accounting firm | |||||||
✔ | Responsible for the appointment, retention, termination, compensation and oversight of the independent registered public accounting firm | |||||||
✔ | Reviews process for monitoring compliance with laws, regulations and the Code of Conduct | |||||||
✔ | Approves or ratifies all related person transactions in accordance with the Related Person Transactions Policy |
G. Kampouri Monnas,
Chair
B. Owens
J. Wu
|
✔ | Each member satisfies the heightened independence standards applicable to compensation committee service | ||||||
✔ | Discharges the Board’s responsibilities relating to compensation of the Company’s executives | |||||||
✔ | May not delegate its authority other than to subcommittees | |||||||
✔ | Reviews and recommends to the Board compensation plans, policies and programs | |||||||
✔ | Approves CEO and executive officer compensation, and employment and severance agreements, including change‑in‑control provisions | |||||||
✔ | Provides input and recommendations to the Board regarding the performance objectives for the CEO and other executive officers and their actual performance against such objectives | |||||||
✔ | Annually reviews the succession plans affecting corporate and other key management positions | |||||||
✔ | Reviews periodically the Company’s key human resources policies and practices relating to talent sourcing, talent development programs, and organizational engagement and effectiveness | |||||||
✔ | Monitors the Company’s policies, objectives and programs related to diversity, and reviews periodically the Company’s diversity performance in light of appropriate measures | |||||||
✔ | Reviews changing legislation and trends relating to compensation and broader management practices and evaluates impact on the Company | |||||||
✔ | Approves grants and/or awards of stock options, restricted stock units, long-term performance incentives based on total shareholder return, and other forms of equity-based compensation | |||||||
✔ | Receives recommendations annually from the CEO regarding the compensation levels of our other executive officers, including salary, annual performance incentives and equity compensation | |||||||
✔ | None of the members in 2020 had interlocking relationships within the meaning of SEC rules |
14
|
2021 Proxy Statement |
![]() |
J. Smith,
Chair
I. Marey-Semper
R. Wunderlich
|
✔ | Comprised solely of independent directors | ||||||
✔ | Identifies, evaluates and recommends to the Board individuals qualified to stand for election as directors, including nominations received from Board members, stockholders or outside parties | |||||||
✔ | Develops and recommends to the Board, Aptar’s corporate governance principles and standards to be applied in determining director independence | |||||||
✔ | Oversees annual evaluations of the Board, its committees and management, and the effectiveness of the Board as a working group | |||||||
✔ | Reviews and recommends to the Board appropriate compensation for non-employee directors, taking into consideration, among other items, director compensation levels of companies with similar annual revenues as Aptar | |||||||
✔ | Makes recommendations to the Board regarding changes to the size and composition of the Board or any Board committee | |||||||
✔ | Reviews the Company's efforts with regard to environmental, social, and governance matters, including with respect to the Company's annual sustainability report |
![]() |
2021 Proxy Statement |
15
|
16
|
2021 Proxy Statement |
![]() |
9 of 10 current directors are independent in accordance with the NYSE listing standards | |||||
Director | Independent | ||||
G. Fotiades | ✔ | ||||
M. Gomez Montiel | ✔ | ||||
G. Kampouri Monnas | ✔ | ||||
A. Kramvis | ✔ | ||||
I. Marey-Semper | ✔ | ||||
B. Owens | ✔ | ||||
J. Smith | ✔ | ||||
J. Wu | ✔ | ||||
R. Wunderlich | ✔ | ||||
S. Tanda* |
![]() |
2021 Proxy Statement |
17
|
18
|
2021 Proxy Statement |
![]() |
![]() |
2021 Proxy Statement |
19
|
Name | Audit |
Management
Development and
Compensation
|
Corporate
Governance
|
||||||||
G. Fotiades (I) | |||||||||||
M. Gomez Montiel (I) |
X
*
|
||||||||||
G. Kampouri Monnas (I) |
X
*
|
||||||||||
A. Kramvis (I) | X | ||||||||||
I. Marey-Semper (I) | X | ||||||||||
B. Owens (I) | X |
X
|
|||||||||
J. Smith (I) |
X
*
|
||||||||||
S. Tanda | |||||||||||
J. Wu (I) | X | ||||||||||
R. Wunderlich (I) | X | ||||||||||
Number of Meetings in 2020 | 9 | 7 | 4 |
20
|
2021 Proxy Statement |
![]() |
Board Members (non-employee)* | ||||||||||||||||||||||||||||||||||||||
![]() |
•
Received an annual retainer of $100,000.
•
Chairman received an annual retainer of $190,000. **
•
These amounts are paid to directors after they are elected by shareholders at our annual meeting
|
|||||||||||||||||||||||||||||||||||||
![]() |
Received an equity grant under the 2018 Equity Incentive Plan with a grant date fair value equal to approximately $140,000, except for the Chairman of the Board, who received an equity grant with a grant date fair value equal to approximately $160,000. Accordingly, on May 6, 2020, each non‑employee director (other than the Chairman of the Board) was granted 1,354 RSUs and the Chairman of the Board was granted 1,547 RSUs. The 2020 RSUs vest on May 4, 2021, subject to the non‑employee director’s continued service through such date. | |||||||||||||||||||||||||||||||||||||
![]() |
Each director is eligible to participate in Aptar’s matching gift program, which matches eligible charitable donations by employees and non‑employee directors up to an aggregate of $6,000 annually per person. | |||||||||||||||||||||||||||||||||||||
ADDITIONAL RETAINERS FOR COMMITTEE SERVICE | ||||||||||||||||||||||||||||||||||||||
Audit Committee | Management Development & Compensation Committee | Corporate Governance Committee | ||||||||||||||||||||||||||||||||||||
![]() |
•
Chairperson: $17,000
|
![]() |
•
Chairperson: $15,000
|
![]() |
•
Chairperson: $10,000
|
|||||||||||||||||||||||||||||||||
•
Members: $11,000
|
•
Members: $7,000
|
•
Members: $7,000
|
![]()
Cash
|
Annual cash payments are commensurate with our peers and allow us to attract and retain an experienced group of directors. | |||||||
![]()
Equity
|
Equity grants facilitate alignment with stockholder interests. | |||||||
![]()
Charitable Contributions
|
Directors are eligible to participate in our gift matching program which allows us to extend our charitable reach into the community. |
![]() |
2021 Proxy Statement |
21
|
Name |
Fees Earned
or Paid in Cash ($) |
Stock Awards
($)(1)(2) |
Total
($) |
|||||||||||||||||
G. Fotiades | 190,000 | 160,000 | 350,000 | |||||||||||||||||
M. Gomez Montiel | 128,000 | 140,000 | 268,000 | |||||||||||||||||
G. Kampouri Monnas | 122,000 | 140,000 | 262,000 | |||||||||||||||||
A. Kramvis | 111,000 | 140,000 | 251,000 | |||||||||||||||||
I. Marey-Semper | 107,000 | 140,000 | 247,000 | |||||||||||||||||
B. Owens | 111,000 | 140,000 | 251,000 | |||||||||||||||||
J. Smith | 117,000 | 140,000 | 257,000 | |||||||||||||||||
J. Wu | 107,000 | 140,000 | 247,000 | |||||||||||||||||
R. Wunderlich | 107,000 | 140,000 | 247,000 |
22
|
2021 Proxy Statement |
![]() |
PROPOSAL 2—ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION |
The Board of Directors recommends a vote
FOR
the following non-binding resolution:
“Resolved, that the compensation of the Company’s NEOs, as disclosed pursuant to the executive compensation disclosure rules of the SEC, including the CD&A, tabular disclosures, and other narrative executive compensation disclosures in this proxy statement, is hereby approved.”
|
![]() |
2021 Proxy Statement |
23
|
PROPOSAL 3—RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2021 |
The Board of Directors and the Audit Committee recommend a vote
FOR
the ratification of the appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2021.
|
24
|
2021 Proxy Statement |
![]() |
Fee Category | 2020 | % of Total | 2019 | % of Total | ||||||||||||||||||||||
Audit Fees | $ | 3,944,000 | 85 | % | $ | 3,795,000 | 87 | % | ||||||||||||||||||
Audit-Related Fees | 153,000 | 3 | % | 3,000 | — | |||||||||||||||||||||
Tax Fees | 295,000 | 6 | % | 241,000 | 6 | % | ||||||||||||||||||||
All Other Fees | 273,000 | 6 | % | 317,000 | 7 | % | ||||||||||||||||||||
Total Fees | $ | 4,665,000 | 100 | % | $ | 4,356,000 | 100 | % |
![]() |
2021 Proxy Statement |
25
|
EXECUTIVE OFFICER COMPENSATION |
Named Executive Officer | Title | ||||
Stephan B. Tanda | President and Chief Executive Officer (“CEO”) | ||||
Robert W. Kuhn | Executive Vice President, Chief Financial Officer (“CFO”) | ||||
Gael Touya | President of Aptar Pharma segment | ||||
Marc Prieur | President of Aptar Beauty + Home Segment | ||||
Xiangwei Gong | President of Aptar Asia |
$2.9 billion
Record Reported Sales
|
$214 million
Annual net income
|
$3.21
Annual diluted earnings per share
|
||||||
$570 million
Record Annual Cash Flow from Operations
|
(27%) and (30%)
Reduction in Total Recordable Incident Rate (TRIR), and Lost Time Frequency Rate (LTFR), respectfully, from the prior year
|
27th year
27th consecutive year of paying
an increased aggregate annual dividend amount
|
26
|
2021 Proxy Statement |
![]() |
![]() |
2021 Proxy Statement |
27
|
Environmental, Social and Governance Enhancements | ||||||||
In 2020, we achieved the following corporate social responsibility benchmarks: | ||||||||
Top 100 Most Responsible
Named one of "America's Most Responsible Companies 2021" by Newsweek and is ranked in the top 100 among 400 U.S. companies.
|
Top 100 Most Sustainable
Named one of the "Top 100 Most Sustainable U.S. Companies" by Barron's as part of their 2019 ranking.
|
United Nations Global Compact
Joined the United Nations (UN) Global Compact, the world's largest citizenship initiative, which focuses on universal principles in the areas of human rights, labor, environment and anti-corruption.
|
||||||
Gender and Diversity KPI Alliance
Joined the Gender and Diversity KPI Alliance, whose aim is the adoption and use of a set of Key Performance Indicators to measure gender and diversity in their companies and organizations.
|
ISS Prime Status
In December of 2020 we were upgraded to Prime status with ISS ESG, one of the leading rating agencies for sustainable investments.
|
CDP "A" List
Of the 5,800+ companies that disclose environmental metrics through the CDP, Aptar is among the 270 companies awarded an A score for Climate Change and also named a Superior Engagement Leader.
|
||||||
Partnering with CARE
Furthering women's education and economic empowerment. Early sponsor of the Fast + Fair COVID-19 Vaccine Response Campaign.
|
Gender Diversity Index ETF (SHE)
Aptar is included in the SPDR® SSGA Gender Diversity Index ETF (SHE) which invests in companies that rank among the highest in gender diversity within senior leadership.
|
Eco-efficient Operations
At year-end 2020, approximately 85% of our global electricity consumption is coming from renewable sources: 53% of Aptar sites were certified as "Landfill Free" through our internal program and globally we re-used or recycled more than 75% of all operational wastes.
|
28
|
2021 Proxy Statement |
![]() |
Governance elements supporting compensation philosophies and objectives | |||||
An independent Management Development and Compensation Committee | |||||
Compensation Consultant retained by and reporting directly to the Management Development and Compensation Committee | |||||
Pay that is designed to be competitive, with a significant portion delivered as performance-based or at‑risk compensation.
–
A significant portion of our targeted annual compensation is performance-based and/or subject to forfeiture (“at‑risk”), with emphasis on variable pay to reward short- and long-term performance measured against pre‑established objectives determined by our Company’s strategy and aligned with stockholder value creation.
–
For 2020, fixed compensation comprised only 17% of the target annual direct compensation (defined as base salary, annual incentive target and target grant date fair value of annual equity awards) for our CEO while variable compensation in the form of annual incentive target and target grant date fair value of annual equity awards comprised the remaining 83% of target annual direct compensation for our CEO. On average, approximately 76% of the target annual direct compensation for the other NEOs consisted of variable compensation.
|
|||||
Emphasis on future pay opportunity vs. current pay
–
Our long-term incentive awards are equity-based and have multi-year vesting provisions to encourage retention.
–
For 2020, long-term incentive compensation comprised approximately 65% of the target annual direct compensation for our CEO and, on average, approximately 50% of the target annual direct compensation for the other NEOs.
|
|||||
Mix of performance metrics supportive of our business strategy and compensation objectives | |||||
![]() |
2021 Proxy Statement |
29
|
Element | Description | Purpose | Factors Influencing Amount | |||||||||||||||||
Salary | Fixed cash compensation | Facilitate attraction and retention | Experience, market data, individual role and responsibilities and individual performance | |||||||||||||||||
Reviewed annually and adjusted if appropriate | Recognize individual’s skills, competencies and experience | |||||||||||||||||||
Annual Short-Term Incentives (“STI”) | Variable cash incentive compensation based on improvements in performance from the prior year | Provide an incentive to achieve performance goals that are deemed critical to the business, our strategy and aligned with stockholder value creation | Annual target opportunity determined annually based on market data, individual role and responsibilities; payout based on Company and Segment/unit performance compared to prior year | |||||||||||||||||
Company and Segment/unit performance measured by improvements in Adjusted EBITDA and core sales (1) | ||||||||||||||||||||
Capped payouts if maximum goals are met | Motivate improvement in Company performance from the prior year | |||||||||||||||||||
Participants may elect to receive up to 50% of STI in RSUs. An additional 20% of election is granted in RSUs. | ||||||||||||||||||||
Long-term Incentives (“LTI”) |
PRSUs vest based on Company performance over 3 years in two areas:
1)
Adjusted ROIC based on internally established objectives
2)
TSR relative to the S&P 400 Mid Cap companies (2)
|
Build ownership and align with stockholders’ interests | Intended target amount of all LTI awards is based on individual role and responsibilities and market data; for PRSUs, vesting only occurs if a threshold level of achievement is attained | |||||||||||||||||
Provide an incentive to achieve performance goals that are deemed critical to the business, our strategy and aligned with stockholder value creation | ||||||||||||||||||||
Facilitate retention | ||||||||||||||||||||
RSUs | Build ownership and align with stockholders’ interests | Intended target amount of all LTIP awards is based on individual role and responsibilities and market data; ratable vesting of RSU awards over a three year term. | ||||||||||||||||||
Facilitate retention | ||||||||||||||||||||
Reward long term success and growth |
30
|
2021 Proxy Statement |
![]() |
What the Company Does / Has | What the Company Does Not Do / Have | |||||||||||||
ü | Pay that is reasonable, performance-based and designed to support our business strategy and compensation objectives | û | Tax gross‑up agreements with NEOs, other than those related to relocation benefits or expatriate assignments | |||||||||||
ü | Significant amount of pay that is at-risk (both annual and long-term), with a substantial amount provided in equity (and therefore aligned with stockholders) | |||||||||||||
ü | Stock ownership guidelines, limits on executive officer stock trading and prohibition of hedging or pledging Aptar equity securities | û | Significant perquisites other than common perquisites provided in the context of expatriate assignments or related to relocation | |||||||||||
ü | Employment and change‑in‑control agreements that are designed to be competitive in markets in which we compete for executive talent |
99%
approval |
The Management Development and Compensation Committee considered the continued support that our proposal on executive compensation received from stockholders at our 2020 annual meeting of stockholders, at which approximately 99% of votes cast (excluding abstentions and broker non-votes) were in favor of our compensation policies and practices. The Management Development and Compensation Committee determined that the Company's executive compensation philosophy and objectives and compensation elements continued to be appropriate and no changes were made to our executive compensation program in response to the advisory vote. |
![]() |
2021 Proxy Statement |
31
|
![]() |
![]() |
![]() |
||||||||||||
We benchmark against size-appropriate published general industry survey data for all roles. | We review proxy data from the Company’s compensation peer group for the CEO and CFO roles. | We understand the importance of retaining a talented senior management team. We review past compensation levels and place a high value on the experience of senior managers. |
32
|
2021 Proxy Statement |
![]() |
2020 Peer Group Companies: | ||||||||
Albemarle Corp. | McCormick & Company | |||||||
Ashland Global Holdings Inc. | Sealed Air Corp* | |||||||
Berry Global Group, Inc.* | Sensient Technologies, Inc.* | |||||||
Catalent, Inc. | Silgan Holdings Inc.* | |||||||
CCL Industries, Inc. | Sonoco Products Co.* | |||||||
Hill-Rom Holdings, Inc. | Stericycle, Inc. | |||||||
ICU Medical, Inc. | STERIS plc | |||||||
Ingredion Inc. | Teleflex Inc. | |||||||
International Flavors & Fragrances* | West Pharmaceutical Services, Inc.* | |||||||
*Company in Aptar's 2019 Peer Group |
![]() |
2021 Proxy Statement |
33
|
Name | 2020 Salary | 2019 Salary | % Increase | |||||||||||||||||
Tanda | $ | 1,105,000 | $ | 1,071,000 | 3 | % | ||||||||||||||
Kuhn | $ | 624,000 | $ | 600,000 | 4 | % | ||||||||||||||
Touya(1) | $ | 570,544 | $ | 523,966 | 9 | % | ||||||||||||||
Prieur(2)(3) | $ | 568,757 | $ | 567,158 | — | % | ||||||||||||||
Gong | $ | 464,000 | $ | 450,000 | 3 | % |
34
|
2021 Proxy Statement |
![]() |
2020 STI Performance for Corporate and Segments | |||||||||||||||||||||||||||||||||||
Corporate and
Segments STI Adjusted EBITDA(1) Growth vs Prior Year (Weighted 65% of Target) |
Corporate and Segments Core Sales(2) Growth vs Prior Year
(Weighted 35% of Target) |
||||||||||||||||||||||||||||||||||
Growth Rate Corp & Segments(3) | Growth Rate Asia (3) | Performance Factor | Corporate(3) |
Food +
Beverage(3) |
Beauty +
Home(3) |
Pharma(3) | Asia(3) |
Performance
Factor |
|||||||||||||||||||||||||||
<0% | <0% | — | % | <0% | <0% | <0% | <0% | <0% | — | % | |||||||||||||||||||||||||
— | % | 8 | % | 50 | % | — | % | — | % | — | % | — | % | 5 | % | 50 | % | ||||||||||||||||||
5 | % | 13 | % | 100 | % | 4 | % | 6 | % | 3 | % | 6 | % | 10 | % | 100 | % | ||||||||||||||||||
7 | % | 14.5 | % | 125 | % | 5 | % | 7 | % | 4 | % | 7 | % | 12 | % | 125 | % | ||||||||||||||||||
10 | % | 16 | % | 150 | % | 6 | % | 8 | % | 5 | % | 8 | % | 13 | % | 150 | % | ||||||||||||||||||
13 | % | 17 | % | 175 | % | 6.5 | % | 9 | % | 5.5 | % | 9 | % | 14 | % | 175 | % | ||||||||||||||||||
15 | % | 18 | % | 200 | % | 7 | % | 10 | % | 6 | % | 10 | % | 15 | % | 200 | % |
Actual Growth Rates | |||||||||||
Corporate and Segments STI Adjusted
EBITDA Growth vs Prior Year (Weighted 65% of Target) |
Corporate and Segments Core
Sales Growth vs Prior Year (Weighted 35% of Target) |
||||||||||
Corporate | (3.9) | % | (0.3) | % | |||||||
Food + Beverage | 4.2 | % | (1.8) | % | |||||||
Beauty + Home | (42.6) | % | (7.3) | % | |||||||
Pharma | 9.8 | % | 6.3 | % | |||||||
Asia | 8.0 | % | 6.5 | % |
![]() |
2021 Proxy Statement |
35
|
36
|
2021 Proxy Statement |
![]() |
NEO |
2020 Base
Salary |
Target % | Target $ |
Performance
Factor(3) |
2020 STI | |||||||||||||||||||||||||||
Tanda | $ | 1,105,000 | 115 | % | $1,270,750 | 23.3 | % | $ | 296,561 | |||||||||||||||||||||||
Kuhn | $ | 624,000 | 85 | % | $530,400 | 23.3 | % | $ | 123,782 | |||||||||||||||||||||||
Touya(1) | $ | 570,544 | 75 | % | $427,908 | 89.8 | % | $ | 411,695 | |||||||||||||||||||||||
Prieur(2) | $ | 568,757 | 75 | % | $426,568 | 9.3 | % | $ | 40,985 | |||||||||||||||||||||||
Gong | $ | 464,000 | 75 | % | $348,000 | 42.5 | % | $ | 147,848 |
![]() |
2021 Proxy Statement |
37
|
NEO | Target Value of LTI award(1) | |||||||
Tanda | $ | 4,420,000 | ||||||
Kuhn | $ | 1,248,000 | ||||||
Touya | $ | 937,519 | ||||||
Prieur | $ | 946,510 | ||||||
Gong | $ | 812,000 |
38
|
2021 Proxy Statement |
![]() |
Performance Level | Company TSR Percentile Rank as compared to the S&P 400 MidCap | % of Target Shares to Vest | ||||||
Below Threshold | Below 25th percentile | —% | ||||||
Threshold | 25th percentile | 50% | ||||||
Target | 50th percentile | 100% | ||||||
Maximum | 75th percentile | 200% |
![]() |
2021 Proxy Statement |
39
|
Performance Objective | Below Threshold (0% Vesting) | Threshold (50% Vesting) | Target (100% Vesting) | Maximum (200% Vesting) | Actual Results | Vesting Percentage | ||||||||||||||
Adjusted ROIC (1) | >11.4% | 11.4 | % | 13.4 | % | 15.4 | % | 10.4 | % | 0% | ||||||||||
Company TSR Percentile Rank vs. S&P 400 MidCap Constituent Company Returns | Below 25th Percentile | 25th Percentile | 50th Percentile | 75th Percentile | 82.5th Percentile | 200 | % |
NEO | Target PRSUs | Earned PRSUs | ||||||
Tanda | 16,621 | 18,728 | ||||||
Kuhn | 5,417 | 6,104 | ||||||
Touya | 4,953 | 5,580 | ||||||
Prieur | 1,194 | 1,346 |
40
|
2021 Proxy Statement |
![]() |
Executive Officer | Former Requirement | New Requirement |
Ownership Level
Requirement Status |
||||||||||||||
Tanda | 5 X Base Salary | 6 X Base Salary | Exceeds Guideline | ||||||||||||||
Kuhn | 1 X Base Salary | 3 X Base Salary | Exceeds Guideline | ||||||||||||||
Touya | 1 X Base Salary | 3 X Base Salary | Exceeds Guideline | ||||||||||||||
Prieur | 1 X Base Salary | 3 X Base Salary | Exceeds Guideline | ||||||||||||||
Gong | 1 X Base Salary | 3 X Base Salary | Exceeds Guideline |
![]() |
2021 Proxy Statement |
41
|
Management Development and Compensation Committee | |||||
Giovanna Kampouri Monnas (Chair)
Craig Owens* Jesse Wu |
42
|
2021 Proxy Statement |
![]() |
Name and Principal Position | Year |
Salary
($) |
Bonus
($) |
Stock
Awards ($)(1) |
Non‑Equity
Incentive Plan Compensation ($)(2) |
Changes in
Pension Value and Nonqualified Deferred Compensation Earnings ($)(3) |
All Other
Compensation ($)(4) |
Total
($) |
||||||||||||||||||||||||||||||||||||||||||
Stephan B. Tanda | 2020 | 1,105,000 | — | 4,929,983 | 148,280 | 763,195 | 72,364 | 7,018,822 | ||||||||||||||||||||||||||||||||||||||||||
President and | 2019 | 1,071,200 | — | 4,577,547 | 484,976 | 773,896 | 1,010,421 | 7,918,040 | ||||||||||||||||||||||||||||||||||||||||||
Chief Executive Officer | 2018 | 1,030,000 | — | 4,230,125 | 950,325 | 288,445 | 1,540,290 | 8,039,185 | ||||||||||||||||||||||||||||||||||||||||||
Robert W. Kuhn | 2020 | 624,000 | — | 1,416,049 | 61,891 | 669,345 | 22,856 | 2,794,141 | ||||||||||||||||||||||||||||||||||||||||||
Executive Vice President | 2019 | 600,246 | — | 2,101,520 | 200,864 | 745,315 | 21,612 | 3,669,557 | ||||||||||||||||||||||||||||||||||||||||||
and Chief Financial Officer | 2018 | 575,500 | 125,000 | 1,572,584 | 346,293 | 43,200 | 20,529 | 2,683,106 | ||||||||||||||||||||||||||||||||||||||||||
Gael Touya(5) | 2020 | 570,544 | — | 1,756,116 | 288,187 | — | 49,245 | 2,664,092 | ||||||||||||||||||||||||||||||||||||||||||
President, | 2019 | 523,966 | — | 1,143,546 | 271,009 | 1,335,794 | 36,379 | 3,310,694 | ||||||||||||||||||||||||||||||||||||||||||
Aptar Food + Beverage | 2018 | 515,841 | — | 1,131,212 | 263,145 | — | 37,896 | 1,948,094 | ||||||||||||||||||||||||||||||||||||||||||
Marc Prieur (6) President, Aptar Beauty + Home | 2020 | 568,757 | — | 1,767,645 | 40,985 | 119,317 | 20,924 | 2,517,628 | ||||||||||||||||||||||||||||||||||||||||||
Xiangwei Gong | 2020 | 464,000 | — | 1,561,666 | 73,924 | 132,373 | 187,133 | 2,419,096 | ||||||||||||||||||||||||||||||||||||||||||
President, Aptar Asia | 2019 | 450,000 | — | 787,500 | 106,313 | 45,639 | 179,537 | 1,568,989 | ||||||||||||||||||||||||||||||||||||||||||
2018 | 96,196 | 200,000 | 1,000,000 | 60,000 | — | 72,280 | 1,428,476 |
Amounts Included In
Stock Awards Column Above Taken In Lieu Of Cash ($)/(# RSUs) |
Amounts Included In
Stock Awards Column For Additional 20% On Amounts Taken In Lieu of Cash ($)/(# RSUs) |
Combined Total
($)/(# RSUs) |
|||||||||||||||||||||||||||||||||
Tanda | $ | 148,281 | / | 1,163 | $ | 29,656 | / | 233 | $ | 177,937 | / | 1,396 | |||||||||||||||||||||||
Kuhn | $ | 61,891 | / | 486 | $ | 12,378 | / | 97 | $ | 74,269 | / | 583 | |||||||||||||||||||||||
Touya | $ | 123,508 | / | 969 | $ | 24,701 | / | 194 | $ | 148,209 | / | 1,163 | |||||||||||||||||||||||
Gong | $ | 73,924 | / | 566 | $ | 14,785 | / | 112 | $ | 88,709 | / | 678 |
![]() |
2021 Proxy Statement |
43
|
# RSUs | $ | ||||||||||
Tanda | 21,811 | $ | 1,768,000 | ||||||||
Kuhn | 6,158 | $ | 499,167 | ||||||||
Touya | 4,626 | $ | 374,984 | ||||||||
Prieur | 4,671 | $ | 378,631 | ||||||||
Gong | 4,007 | $ | 324,807 |
# PRSUs | $ | ||||||||||
Tanda | 33,300 | $ | 2,984,046 | ||||||||
Kuhn | 9,403 | $ | 842,613 | ||||||||
Touya | 7,063 | $ | 632,923 | ||||||||
Prieur | 7,131 | $ | 639,014 | ||||||||
Gong | 6,117 | $ | 548,150 |
44
|
2021 Proxy Statement |
![]() |
All Other
Stock Awards: Number of Shares of Stock or Units (#)(4) |
Exercise or
Base Price of Option Awards ($/Sh) |
Grant Date
Fair Value of Stock and Option Awards ($)(5) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Estimated Possible Payouts
Under Non-Equity Incentive Plan Awards(2) |
Estimated Possible Payouts
Under Equity Incentive Plan Awards(3) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Name |
Grant
Date |
Approval Date |
Grant
Type(1) |
Threshold
($) |
Target
($) |
Maximum
($) |
Threshold
(#) |
Target
(#) |
Maximum
(#) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S. Tanda | 2/25/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 5,590 | — | 581,971 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 21,811 | — | 1,768,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | PRSU | — | — | — | 16,650 | 33,300 | 66,600 | — | — | 2,984,046 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— | — | STI | — | 1,270,750 | 2,541,500 | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
R. Kuhn | 2/25/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 2,315 | — | 241,036 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 6,158 | — | 499,167 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | PRSU | — | — | — | 4,702 | 9,403 | 18,806 | — | — | 842,613 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— | — | STI | — | 530,400 | 1,060,800 | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
G. Touya | 2/25/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 2,082 | — | 216,808 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 4,626 | — | 374,984 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 7,534 | — | 600,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | PRSU | — | — | — | 3,532 | 7,063 | 14,126 | — | — | 632,923 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— | — | STI | — | 427,908 | 855,816 | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
M. Prieur | 1/2/2020 | 10/25/2019 | PRSU | — | — | — | 3,425 | 6,850 | 13,700 | — | — | 750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 4,671 | — | 378,631 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | PRSU | — | — | — | 3,566 | 7,131 | 14,262 | — | — | 639,014 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— | — | STI | — | 426,568 | 853,136 | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
X. Gong | 3/23/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 4,007 | — | 324,807 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | RSU | — | — | — | — | — | — | 7,534 | 600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3/23/2020 | 2/5/2020 | PRSU | — | — | — | 3,059 | 6,117 | 12,234 | — | — | 548,150 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
— | — | STI | — | 348,000 | 696,000 | — | — | — | — | — | — |
![]() |
2021 Proxy Statement |
45
|
46
|
2021 Proxy Statement |
![]() |
Option Awards | Stock Awards | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Name |
Grant
Date |
Number of
Securities Underlying Unexercised Options (#) Exercisable |
Option
Exercise Price ($)(1) |
Option
Expiration Date |
Number of
Shares or Units of Stock That Have Not Vested (#)(2) |
Market Value
of Shares or Units of Stock That Have Not Vested ($)(3) |
Equity
Incentive Plan Awards Number of Unearned Shares, Units or Other Rights that have Not Vested (#)(4) |
Equity
Incentive Plan Awards Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) |
||||||||||||||||||||||||||||||||||||||||||||||||
S. Tanda | — | — | — | 52,496 | 7,186,177 | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
— | — | — | — | — | 76,373 | 10,454,700 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/10/2017 | 133,838 | 74.79 | 2/10/2027 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
R. Kuhn | — | — | — | 25,994 | 3,558,319 | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
— | — | — | — | — | 21,445 | 2,935,606 | ||||||||||||||||||||||||||||||||||||||||||||||||||
1/11/2012 | 30,000 | 51.80 | 1/11/2022 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
1/16/2013 | 50,000 | 51.57 | 1/16/2023 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
1/15/2014 | 50,000 | 68.00 | 1/15/2024 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
1/14/2015 | 50,663 | 64.60 | 1/14/2025 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
2/5/2016 | 54,390 | 71.12 | 2/5/2026 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
2/10/2017 | 69,620 | 74.79 | 2/10/2027 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
G. Touya | — | — | — | 18,376 | 2,515,491 | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
— | — | — | — | — | 16,540 | 2,264,161 | ||||||||||||||||||||||||||||||||||||||||||||||||||
2/5/2016 | 42,735 | 71.12 | 2/5/2026 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
2/10/2017 | 59,072 | 74.79 | 2/10/2027 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
M. Prieur | — | — | — | 9,901 | 1,355,348 | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
— | — | — | — | — | 23,892 | 3,270,576 | ||||||||||||||||||||||||||||||||||||||||||||||||||
1/15/2014 | 6,500 | 68.00 | 1/15/2024 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
1/14/2015 | 4,500 | 64.60 | 1/14/2025 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
2/5/2016 | 6,500 | 71.12 | 2/5/2026 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
2/10/2017 | 6,500 | 74.79 | 2/10/2027 | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
X. Gong | — | — | — | 16,831 | 2,303,996 | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
— | — | — | — | — | 14,396 | 1,970,668 |
Vesting in 2021 | Vesting in 2022 | Vesting in 2023 | Total | ||||||||||||||||||||
Tanda | 25,169 | 18,192 | 9,135 | 52,496 | |||||||||||||||||||
Kuhn | 8,674 | 14,495 | 2,825 | 25,994 | |||||||||||||||||||
Touya | 5,157 | 3,448 | 9,771 | 18,376 | |||||||||||||||||||
Prieur | 4,337 | 4,007 | 1,557 | 9,901 | |||||||||||||||||||
Gong | 5,595 | 2,366 | 8,870 | 16,831 |
![]() |
2021 Proxy Statement |
47
|
Stock Options | Stock Awards Vested | |||||||||||||||||||||||||||||||
Name |
Grant
Type(1) |
Number of
Shares Acquired on Exercise (#) |
Value
Realized on Exercise ($)(2) |
Number of
Shares Acquired on Vesting (#) |
Value Realized on
Vesting ($)(3) |
|||||||||||||||||||||||||||
Tanda | RSU | — | — | 16,034 | 1,563,656 | |||||||||||||||||||||||||||
PRSU | — | — | 18,728 | 2,563,676 | ||||||||||||||||||||||||||||
Kuhn | RSU | — | — | 23,457 | 2,568,300 | |||||||||||||||||||||||||||
PRSU | — | — | 6,104 | 835,577 | ||||||||||||||||||||||||||||
Touya | RSU | — | — | 11,538 | 1,255,347 | |||||||||||||||||||||||||||
PRSU | — | — | 5,580 | 763,846 | ||||||||||||||||||||||||||||
Prieur | RSU | — | — | 2,779 | 309,273 | |||||||||||||||||||||||||||
PRSU | — | — | 1,346 | 184,254 | ||||||||||||||||||||||||||||
2,500 | 161,079 | — | — | |||||||||||||||||||||||||||||
Gong | RSU | — | — | 4,259 | 489,795 |
48
|
2021 Proxy Statement |
![]() |
![]() |
2021 Proxy Statement |
49
|
50
|
2021 Proxy Statement |
![]() |
![]() |
2021 Proxy Statement |
51
|
Name | Plan Name(1) |
Number of
Years of Credited Service (#) |
Present
Value of Accumulated Benefit ($) |
Payments
During Last Fiscal Year ($) |
||||||||||||||||||||||
Tanda | Employees’ Retirement Plan | 4 | 223,320 | — | ||||||||||||||||||||||
Supplemental Retirement Plan | 4 | 1,955,152 | — | |||||||||||||||||||||||
Kuhn | Employees’ Retirement Plan | 33 | 1,253,726 | — | ||||||||||||||||||||||
Supplemental Retirement Plan | 33 | 1,848,948 | — | |||||||||||||||||||||||
Touya | Retirement Indemnities | 26 | 434,673 | — | ||||||||||||||||||||||
Pension Plan | 26 | 1,869,644 | — | |||||||||||||||||||||||
Prieur | Employees’ Retirement Plan | 8 | 351,230 | — | ||||||||||||||||||||||
Supplemental Retirement Plan | 8 | — | — | |||||||||||||||||||||||
Gong | Employees’ Retirement Plan | 2 | 106,559 | — | ||||||||||||||||||||||
Supplemental Retirement Plan | 2 | 71,453 | — |
52
|
2021 Proxy Statement |
![]() |
Name |
Normal
Expiration of Employment Agreement |
Voluntary
Termination (1) |
Involuntary
Termination |
Involuntary or
Good Reason Termination After a CIC |
Disability | Death | ||||||||||||||||||||||||||||||||
Tanda | ||||||||||||||||||||||||||||||||||||||
Cash Payment | 2,599,070 | 223,320 | 3,846,120 | 8,779,120 | 736,704 | 1,105,000 | ||||||||||||||||||||||||||||||||
Continuation of Medical/Welfare Benefits | — | — | 103,307 | 206,613 | — | — | ||||||||||||||||||||||||||||||||
Acceleration of Time Vesting RSUs (Value as of 12/31/20) (2) | 6,883,512 | 6,883,512 | 6,883,512 | 7,186,040 | 7,186,040 | 7,186,040 | ||||||||||||||||||||||||||||||||
PRSUs(3) | — | — | — | 6,666,726 | 6,666,726 | 6,666,726 | ||||||||||||||||||||||||||||||||
Total Termination Benefits (4) | 9,482,582 | 7,106,832 | 10,832,939 | 22,838,499 | 14,589,470 | 14,957,766 | ||||||||||||||||||||||||||||||||
Kuhn | ||||||||||||||||||||||||||||||||||||||
Cash Payment | 624,000 | — | 1,248,000 | 3,647,297 | 416,021 | 624,000 | ||||||||||||||||||||||||||||||||
Continuation of Medical/Welfare Benefits | 20,732 | — | — | 51,830 | — | — | ||||||||||||||||||||||||||||||||
Acceleration of Time Vesting RSUs (Value as of 12/31/20) (2) | 3,418,689 | 3,418,689 | 3,418,689 | 3,558,317 | 3,558,317 | 3,558,317 | ||||||||||||||||||||||||||||||||
PRSUs(3) | — | — | — | 1,866,358 | 1,866,358 | 1,866,358 | ||||||||||||||||||||||||||||||||
Total Termination Benefits (4) | 4,063,421 | 3,418,689 | 4,666,689 | 9,123,802 | 5,840,696 | 6,048,675 | ||||||||||||||||||||||||||||||||
Touya | ||||||||||||||||||||||||||||||||||||||
Cash Payment | — | 610,323 | 1,693,240 | 1,586,158 | 406,902 | 610,323 | ||||||||||||||||||||||||||||||||
Continuation of Medical/Welfare Benefits | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Acceleration of Time Vesting RSUs (Value as of 12/31/20) (2) | 1,436,659 | 1,436,659 | 1,436,659 | 1,484,159 | 1,484,159 | 1,484,159 | ||||||||||||||||||||||||||||||||
PRSUs(3) | — | — | — | 1,486,001 | 1,486,001 | 1,486,001 | ||||||||||||||||||||||||||||||||
Total Termination Benefits (4) | 1,436,659 | 2,046,982 | 3,129,899 | 4,556,318 | 3,377,062 | 3,580,483 | ||||||||||||||||||||||||||||||||
Prieur | ||||||||||||||||||||||||||||||||||||||
Cash Payment | 568,757 | 397,137 | 284,379 | 794,274 | 379,190 | 568,757 | ||||||||||||||||||||||||||||||||
Continuation of Medical/Welfare Benefits | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Acceleration of Time Vesting RSUs (Value as of 12/31/20) (2) | — | — | — | 982,734 | 982,734 | 982,734 | ||||||||||||||||||||||||||||||||
PRSUs(3) | — | — | — | 1,291,271 | 1,291,271 | 1,291,271 | ||||||||||||||||||||||||||||||||
Total Termination Benefits (4) | 568,757 | 397,137 | 284,379 | 3,068,279 | 2,653,195 | 2,842,762 | ||||||||||||||||||||||||||||||||
Gong | ||||||||||||||||||||||||||||||||||||||
Cash Payment | 464,000 | — | 928,000 | 1,451,048 | 309,349 | 464,000 | ||||||||||||||||||||||||||||||||
Continuation of Medical/Welfare Benefits | 18,558 | — | — | 46,395 | — | — | ||||||||||||||||||||||||||||||||
Acceleration of Time Vesting RSUs (Value as of 12/31/20) (2) | 1,272,667 | 1,272,667 | 1,272,667 | 1,272,667 | 1,272,667 | 1,272,667 | ||||||||||||||||||||||||||||||||
PRSUs(3) | — | — | — | 1,273,247 | 1,273,247 | 1,273,247 | ||||||||||||||||||||||||||||||||
Total Termination Benefits (4) | 1,755,225 | 1,272,667 | 2,200,667 | 4,043,357 | 2,855,263 | 3,009,914 |
![]() |
2021 Proxy Statement |
53
|
54
|
2021 Proxy Statement |
![]() |
![]() |
2021 Proxy Statement |
55
|
56
|
2021 Proxy Statement |
![]() |
![]() |
2021 Proxy Statement |
57
|
EQUITY COMPENSATION PLAN INFORMATION |
Plan Category |
Number of
Securities to Be Issued Upon Exercise of Outstanding Options, Warrants and Rights (a) |
Weighted
Average Exercise Price of Outstanding Options, Warrants and Rights (b) |
Number of
Securities Remaining Available for Future Issuance under Equity Compensation Plans (excluding Securities reflected in Column (a)) (c) |
|||||||||||||||||||||||||||||
Equity compensation plans approved by stockholders(1) | 5,263,509 | (2) | $ | 70.05 | (3) | 1,090,498 |
58
|
2021 Proxy Statement |
![]() |
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS, DIRECTORS AND MANAGEMENT |
Shares Owned |
Options
Exercisable or RSUs Vesting Within 60 Days of March 12, 2021 |
|||||||||||||||||||
Name |
Number of
Shares(1) |
Percentage (2) | ||||||||||||||||||
The Vanguard Group(3) | 6,555,782 | 9.9 | — | |||||||||||||||||
100 Vanguard Boulevard, | ||||||||||||||||||||
Malvern, PA 19355 | ||||||||||||||||||||
State Farm Mutual | 5,556,069 | 8.4 | 0 | |||||||||||||||||
Automobile Insurance Company(4) | ||||||||||||||||||||
One State Farm Plaza, | ||||||||||||||||||||
Bloomington, IL 61710 | ||||||||||||||||||||
Blackrock, Inc.(5) | 5,460,812 | 8.3 | — | |||||||||||||||||
55 East 52nd Street, | ||||||||||||||||||||
New York, NY 10055 | ||||||||||||||||||||
Eaton Vance Management(6) | 3,935,465 | 6.0 | — | |||||||||||||||||
2 International Place | ||||||||||||||||||||
Boston, MA 02110 | ||||||||||||||||||||
George L. Fotiades | 31,000 | * | 19,000 | |||||||||||||||||
Xiangwei Gong | 203 | * | — | |||||||||||||||||
Maritza Gomez Montiel | 2,977 | * | — | |||||||||||||||||
Giovanna Kampouri Monnas | 9,130 | * | — | |||||||||||||||||
Andreas C. Kramvis | 17,577 | * | 9,500 | |||||||||||||||||
Robert W. Kuhn | 356,185 | * | 304,673 | |||||||||||||||||
Isabel Marey-Semper | 1,257 | * | — | |||||||||||||||||
B. Craig Owens | 2,670 | * | — | |||||||||||||||||
Marc Prieur | 20,004 | * | 15,000 | |||||||||||||||||
Dr. Joanne C. Smith(7) | 43,804 | * | 27,500 | |||||||||||||||||
Stephan B. Tanda | 194,373 | * | 133,838 | |||||||||||||||||
Gael Touya | 118,816 | * | 101,807 | |||||||||||||||||
Jesse Wu | 2,668 | * | — | |||||||||||||||||
Ralf K. Wunderlich | 10,126 | * | — | |||||||||||||||||
All Directors and Executive Officers as a Group(17) persons)(8) | 818,059 | 1.2 | 614,485 |
![]() |
2021 Proxy Statement |
59
|
60
|
2021 Proxy Statement |
![]() |
TRANSACTIONS WITH RELATED PERSONS |
![]() |
2021 Proxy Statement |
61
|
DELINQUENT SECTION 16(a) REPORTS |
62
|
2021 Proxy Statement |
![]() |
AUDIT COMMITTEE REPORT |
Audit Committee | |||||
Maritza Gomez Montiel (Chair)
Andreas C. Kramvis B. Craig Owens |
![]() |
2021 Proxy Statement |
63
|
OTHER MATTERS |
/s/ Kimberly Y. Chainey | |||||
Executive Vice President, General Counsel and Secretary | |||||
Crystal Lake, Illinois
March 26, 2021
|
64
|
2021 Proxy Statement |
![]() |
Frequently Asked Questions
|
![]() |
2021 Proxy Statement |
65
|
Proposal |
Board
recommendation |
For more
information |
||||||
1. To elect the four director nominees named in this proxy statement to terms of office expiring at the annual meeting in 2024 |
FOR
all of the nominees named in this proxy statement for election to the Board of Directors
|
Page
7
|
||||||
2. To approve, on an advisory basis, Aptar’s executive compensation
|
FOR
the resolution to approve executive compensation
|
Page
23
|
||||||
3. To ratify the appointment of the independent registered public accounting firm for 2021 |
FOR
the ratification of the appointment of the independent registered public accounting firm for 2021
|
Page
24
|
66
|
2021 Proxy Statement |
![]() |
4 Ways to Vote: | 3 Voting Options: | 4 Ways to Revoke: | ||||||||||||||||||
![]() |
By Internet:
Aptar encourages stockholders to vote by Internet because it is the least costly method of tabulating votes. You can vote by Internet by following the instructions on the proxy card or the Notice.
|
Vote
FOR
a given nominee or proposal
|
Entering a new vote by Internet or telephone | |||||||||||||||||
![]() |
By Telephone:
You can vote by telephone by following the instructions on the proxy card.
|
Vote
AGAINST
a given nominee or proposal
|
Submitting another signed proxy card with a later date | |||||||||||||||||
![]() |
By Mail:
If you received proxy materials by mail or if you request a paper proxy card, you may elect to vote by mail. To do so, you should sign, date and complete the proxy card you receive and return it in the envelope which accompanied that proxy card.
|
ABSTAIN
from voting on a given nominee or proposal
|
Writing to Aptar’s Corporate Secretary | |||||||||||||||||
![]() |
During the Meeting:
If you attend the virtual annual meeting using your 16-digit control number, you may vote during the annual meeting. Even if you plan to attend the virtual annual meeting, we encourage you to vote in advance by one of the methods specified above.
|
If you return your proxy with no voting instructions marked on a nominee or proposal, your shares will be voted in the manner recommended by the Board on such nominee or proposal as presented in this proxy statement and as the proxy holders may determine in their discretion with respect to any other matters properly presented for a vote at the annual meeting. | Voting during the virtual annual meeting using your 16-digit control number |
![]() |
2021 Proxy Statement |
67
|
68
|
2021 Proxy Statement |
![]() |
![]() |
2021 Proxy Statement |
69
|
70
|
2021 Proxy Statement |
![]() |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Colgate-Palmolive Company | CL |
Performance Food Group Company | PFGC |
Sysco Corporation | SYY |
The Wendy's Company | WEN |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|